Nasdaq

20 stories about Nasdaq
נאסדק

Cybersecurity Company Forescout Jumps on Earnings

11.02.19|Lilach Baumer
The company has gained 17.85% on Nasdaq on Friday after announcing its results Thursday
נאסדק

Electronics 3D Printer Company Nano Dimension Prices Nasdaq Offering at a Discount

04.02.19|Lilach Baumer
The Israel-based company submitted a prospectus to the SEC in November, looking to raise $28.75 million. On Thursday, the company opened its offering, now looking to raise $12 million
משרדי אמדוקס ב רעננה AMDOCS

Amdocs Stock Falls on Warning of Short-Seller Hedge Fund Spruce Point

24.01.19|Lilach Baumer
Amdocs closed 8.95% down on Nasdaq on Wednesday but is currently trending up
נאסדק

Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq

24.01.19|Lilach Baumer
Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering
נאסדק

Medical Device Company Brainsway Wants to Raise $30 Million on Nasdaq

16.01.19|Lilach Baumer
Jerusalem-headquartered Brainsway develops headsets that use magnetic stimulation to treat brain disorders
הדמיה רובוט מגל מערכות

Security Contractor Magal Awarded $2.5 Million Spanish Port Contract

14.01.19|Shir Reiter and Adi Pick
Nasdaq-listed Magal has signed a contract to supply security technology and services to the port of Huelva, Spain
נאסדק

Thoma Bravo Completes Acquisition of Imperva

14.01.19|Lilach Baumer
The technology investment firm announced an agreement to buy Nasdaq-listed information security company Imperva for $2.1 billion in October 2018
נאסדק

Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq

09.01.19|Lilach Baumer
The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter
מיקי מגדל sap ישראל

President of Nice Israel Miki Migdal Leaves Company

02.01.19|Meir Orbach
Migdal led the software company’s enterprise group, which has recently moved the bulk of its activity to the U.S.
default image

KLA-Tencor's $3.4 Billion Orbotech Acquisition Stuck in China

25.12.18|Lilach Baumer
After getting the nod from regulators in the Korea, Israel, the U.S., Taiwan, and Japan, the companies announced Monday the deal is still pending approval in China
default image

As Self-Imposed Acquisition Deadline Grows Near, Orbotech’s Stock Continues Downturn

23.12.18|Lilach Baumer
Consumer electronics company Orbotech’s stock fell 9.12% since the beginning of the month, reaching $54.7 just over a week before its acquisition by KLA-Tencor was expected to be finalized
אורי הדומי מנכ"ל מזור רובוטיקה

Acquisition by Medtronic Complete, Mazor Delists

20.12.18|Lilach Baumer
Medtronic paid $1.3 billion in cash for the Israeli surgical robotics company. Including Medtronic’s existing stake, the deal is valued at $1.7 billion
רמון לגוארטה מנכל פפסיקו דניאל בירנבאום מנכל סודה סטרים מסיבת עיתונאים רכישת סודה סטרים

PepsiCo Completes SodaStream Acquisition

05.12.18|CTech
SodaStream will delist from the Tel Aviv Exchange at Wednesday market close
נאסדק

$10 Million Public Offering Sends Interception Firm’s Stock Plummeting

26.11.18|CTech
Tel Aviv-based Ability Inc. dropped around 46% by Friday market close following its announcement
נאסדק

Electronics 3D Printer Company Nano Dimension Wants to Raise $29 Million on Nasdaq

22.11.18|Lilach Baumer
The Tel Aviv and Nasdaq-listed company submitted a public offering prospectus to the SEC Wednesday
רונן סמואל מנכ"ל חברת קורנית

Under New Management, Printer Maker Kornit Reports 32% Increase in Quarterly Revenues

14.11.18|Dror Reich
In August, HP veteran Ronen Samuel replaced Kornit’s former CEO for the past four years, Gabi Seligsohn
מנכ"ל טאואר ראסל אלוונגר

Tower Semiconductor's Stock Down 21% Following Underwhelming Third Quarter Results

30.10.18|CTech
Tower reported revenues of $323 million for the quarter ending Sept. 30, down 9% compared with the same period last year, and 3.5% short of prior estimates
נאסדק

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
אייל ולדמן מלאנוקס

Mellanox Considers Sale, Says CNBC Report

26.10.18|Lilach Baumer
Mellanox published its preliminary third-quarter results for 2018, reporting its fifth consecutive quarter of record results
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases